Jiejie Xu (Zewei Wang)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 67

Top Topics

Tyrosine Kinase

Gas Chromatography

Regulatory T Cells

Top Venues

British journal of cancer

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Kaifeng Jin, Jingtong Xu, Xiaohe Su, Ziyue Xu, Bingyu Li, Ge Liu, Hailong Liu, Yiwei Wang, Yu Zhu, Le Xu, Weijuan Zhang, Zhaopei Liu, Zewei Wang, Yuan Chang, Jiejie Xu
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma. The Journal of pathology 263 (2) (2024)
Youqi Qiu, Li Liu, Wenbin Jiang, Ziyang Xu, Jiahao Wang, Siyuan Dai, Jianming Guo, Jiejie Xu
NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 12 (1) (2024)
Kaifeng Jin, Jingtong Xu, Xiaohe Su, Ziyue Xu, Bingyu Li, Ge Liu, Hailong Liu, Yiwei Wang, Yu Zhu, Le Xu, Weijuan Zhang, Zhaopei Liu, Zewei Wang, Yuan Chang, Jiejie Xu
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma. The Journal of pathology 263 (2) (2024)
Youqi Qiu, Li Liu, Wenbin Jiang, Ziyang Xu, Jiahao Wang, Siyuan Dai, Jianming Guo, Jiejie Xu
NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 12 (1) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Youqi Qiu, Li Liu, Wenbin Jiang, Ziyang Xu, Jiahao Wang, Siyuan Dai, Jianming Guo, Jiejie Xu
NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 12 (1) (2024)
Kaifeng Jin, Jingtong Xu, Xiaohe Su, Ziyue Xu, Bingyu Li, Ge Liu, Hailong Liu, Yiwei Wang, Yu Zhu, Le Xu, Weijuan Zhang, Zhaopei Liu, Zewei Wang, Yuan Chang, Jiejie Xu
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma. The Journal of pathology (2024)
Yun Gu, Mengyao Sun, Hanji Fang, Fei Shao, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Jieti Wang, Heng Zhang, Jiejie Xu
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British journal of cancer (2024)
Yun Gu, Mengyao Sun, Hanji Fang, Fei Shao, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Jieti Wang, Heng Zhang, Jiejie Xu
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British journal of cancer (2024)
Youqi Qiu, Li Liu, Wenbin Jiang, Ziyang Xu, Jiahao Wang, Siyuan Dai, Jianming Guo, Jiejie Xu
NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 12 (1) (2024)
Kaifeng Jin, Jingtong Xu, Xiaohe Su, Ziyue Xu, Bingyu Li, Ge Liu, Hailong Liu, Yiwei Wang, Yu Zhu, Le Xu, Weijuan Zhang, Zhaopei Liu, Zewei Wang, Yuan Chang, Jiejie Xu
TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma. The Journal of pathology 263 (2) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Xin Liu, Kunpeng Lv, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, He Li, Yun Gu, Ruochen Li, Hongyong He, Jiejie Xu
C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer. British journal of cancer (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Kunpeng Lv, Mengyao Sun, Hanji Fang, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, He Li, Hongyong He, Yun Gu, Ruochen Li, Fei Shao, Jiejie Xu
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. Journal for immunotherapy of cancer 11 (11) (2023)
Puran Zhang, Yun Gu, Jieti Wang, Kunpeng Lv, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Hao Liu, Jiejie Xu
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer. International journal of cancer (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Puran Zhang, Yun Gu, Jieti Wang, Kunpeng Lv, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Hao Liu, Jiejie Xu
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer. International journal of cancer (2023)
Kuan Yu, Yun Gu, Puran Zhang, Hanji Fang, Yifan Cao, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, Hongyong He, Ruochen Li, Jing Qin, He Li, Jiejie Xu
Intratumoral PD-1 + CD8 + T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. British journal of cancer 127 (9) (2022)
Zhaopei Liu, Han Zeng, Kaifeng Jin, Yanze Yu, Runze You, Hongyi Zhang, Chunnan Liu, Xiaohe Su, Sen Yan, Yuan Chang, Li Liu, Le Xu, Jiejie Xu, Yu Zhu, Zewei Wang
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 126 (9) (2022)
Yijia Xu, Han Zeng, Kaifeng Jin, Zhaopei Liu, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. Journal for immunotherapy of cancer 10 (3) (2022)
Yanze Yu, Han Zeng, Kaifeng Jin, Runze You, Zhaopei Liu, Hongyi Zhang, Chunnan Liu, Xiaohe Su, Sen Yan, Yuan Chang, Li Liu, Le Xu, Jiejie Xu, Yu Zhu, Zewei Wang
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII 71 (9) (2022)
Siyuan Dai, Han Zeng, Zhaopei Liu, Kaifeng Jin, Wenbin Jiang, Zewei Wang, Zhiyuan Lin, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Li Liu, Yu Zhu, Le Xu, Yang Qu, Jianming Guo, Jiejie Xu
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma. Journal for immunotherapy of cancer 9 (2) (2022)
Puran Zhang, Yun Gu, Hanji Fang, Yifan Cao, Jieti Wang, Hao Liu, Heng Zhang, He Li, Hongyong He, Ruochen Li, Chao Lin, Jiejie Xu
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer. Journal for immunotherapy of cancer 10 (2) (2022)
Kaifeng Jin, Yanze Yu, Han Zeng, Zhaopei Liu, Runze You, Hongyi Zhang, Chunnan Liu, Xiaohe Su, Sen Yan, Yuan Chang, Le Xu, Jiejie Xu, Yu Zhu, Zewei Wang
CD103 + CD8 + tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer. British journal of cancer 126 (11) (2022)
Sen Yan, Han Zeng, Kaifeng Jin, Fei Shao, Zhaopei Liu, Yuan Chang, Yiwei Wang, Yu Zhu, Zewei Wang, Le Xu, Jiejie Xu
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer. Journal for immunotherapy of cancer 10 (5) (2022)
Jieti Wang, Ruochen Li, Yifan Cao, Yun Gu, Hanji Fang, Yuchao Fei, Kunpeng Lv, Xudong He, Chao Lin, Hao Liu, Heng Zhang, He Li, Hongyong He, Jiejie Xu, Hua Huang
Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer. Nature communications 12 (1) (2021)
Kaifeng Jin, Yifan Cao, Yun Gu, Hanji Fang, Yuchao Fei, Jieti Wang, Xin Liu, Kunpeng Lv, Xudong He, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Heng Zhang, Jiejie Xu
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients. Oncoimmunology 10 (1) (2021)
Quan Zhou, Yangyang Qi, Zewei Wang, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Li Liu, Le Xu, Bo Dai, Jianming Guo, Yu Zhu, Weijuan Zhang, Jiejie Xu
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma. Journal for immunotherapy of cancer 8 (1) (2021)
Mengmeng Sun, Han Zeng, Kaifeng Jin, Zhaopei Liu, Baoying Hu, Chunnan Liu, Sen Yan, Yanze Yu, Runze You, Hongyi Zhang, Yuan Chang, Li Liu, Yu Zhu, Jiejie Xu, Le Xu, Zewei Wang
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer. Cancer immunology, immunotherapy : CII (2021)
Han Zeng, Quan Zhou, Zewei Wang, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Le Xu, Bo Dai, Jianming Guo, Li Liu, Yu Zhu, Jiejie Xu
Stromal LAG-3+ cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture. Journal for immunotherapy of cancer 8 (1) (2021)
Ying Xiong, Zewei Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Jiajun Wang, Yuan Chang, Yu Xia, Yiwei Wang, Li Liu, Yu Zhu, Le Xu, Bo Dai, Qi Bai, Jianming Guo, Jiejie Xu
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients. Journal for immunotherapy of cancer 8 (1) (2021)
Ke Chen, Yun Gu, Yifan Cao, Hanji Fang, Kunpeng Lv, Xin Liu, Xudong He, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu, He Li, Ruochen Li
TIM3+ cells in gastric cancer: clinical correlates and association with immune context. British journal of cancer (2021)
Siyu Xia, Yun Gu, Haijian Zhang, Yuchao Fei, Yifan Cao, Hanji Fang, Jieti Wang, Chao Lin, Heng Zhang, He Li, Hongyong He, Jiejie Xu, Ruochen Li, Hao Liu, Weijuan Zhang
Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer. Oncoimmunology 10 (1) (2021)
Ruiting Ye, Han Zeng, Zhaopei Liu, Kaifeng Jin, Chunnan Liu, Sen Yan, Yanze Yu, Runze You, Hongyi Zhang, Yuan Chang, Yiwei Wang, Li Liu, Yu Zhu, Jiejie Xu, Le Xu, Zewei Wang
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis. Cancer immunology, immunotherapy : CII (2021)
Quan Zhou, Hongyu Zhang, Zewei Wang, Han Zeng, Zhaopei Liu, Qiuren Huang, Zhiyuan Lin, Yang Qu, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Li Liu, Bo Dai, Jianming Guo, Yu Zhu, Le Xu, Jiejie Xu
Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer. International journal of cancer 147 (12) (2020)
Zhuoyi Xiang, Quan Zhou, Han Zeng, Zewei Wang, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Li Liu, Yu Zhu, Le Xu, Bo Dai, Jiajun Wang, Jianming Guo, Jiejie Xu
Intratumoral CCR5+ neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses. Oncoimmunology 9 (1) (2020)
Tao Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Jialiang Shao, Zewei Wang, Ying Xiong, Jiajun Wang, Qi Bai, Yu Xia, Yiwei Wang, Li Liu, Yu Zhu, Le Xu, Bo Dai, Jianming Guo, Yuan Chang, Xiang Wang, Jiejie Xu
CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII 69 (9) (2020)
Yaohui Li, Zewei Wang, Wenbin Jiang, Han Zeng, Zhaopei Liu, Zhiyuan Lin, Yang Qu, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yiwei Wang, Li Liu, Yu Zhu, Le Xu, Yu Xia, Jianming Guo, Jiejie Xu
Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response. Oncoimmunology 9 (1) (2020)
Yu Qi, Yu Xia, Zhiyuan Lin, Yang Qu, Yangyang Qi, Yifan Chen, Quan Zhou, Han Zeng, Jiajun Wang, Yuan Chang, Qi Bai, Yiwei Wang, Yu Zhu, Le Xu, Lingli Chen, Yunyi Kong, Weijuan Zhang, Bo Dai, Li Liu, Jianming Guo, Jiejie Xu
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients. Cancer immunology, immunotherapy : CII 69 (8) (2020)
Quan Zhou, Zewei Wang, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Jiajun Wang, Yuan Chang, Qi Bai, Li Liu, Yu Zhu, Le Xu, Bo Dai, Jianming Guo, Yu Xia, Yiwei Wang, Jiejie Xu
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin+ cell abundance. Oncoimmunology 9 (1) (2020)
Kunpeng Lv, Ruochen Li, Yifan Cao, Yun Gu, Xin Liu, Xudong He, Kaifeng Jin, Hanji Fang, Yuchao Fei, Mingsu Shi, Hao Liu, He Li, Hongyong He, Chao Lin, Heng Zhang, Jiejie Xu
Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients. International journal of cancer 148 (3) (2020)
Xin Liu, Yifan Cao, Kunpeng Lv, Yun Gu, Kaifeng Jin, Xudong He, Hanji Fang, Yuchao Fei, Mingsu Shi, Chao Lin, Hao Liu, He Li, Hongyong He, Jiejie Xu, Ruochen Li, Heng Zhang
Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture. Oncoimmunology 9 (1) (2020)
Baoying Hu, Jiejie Xu, Han Zeng, Yangyang Qi, Yifan Chen, Yuan Chang, Qi Bai, Yu Xia, Li Liu, Yu Zhu, Bo Dai, Jianming Guo, Weijuan Zhang
Blockade of DC-SIGN+ Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder Cancer. Cancer research 80 (8) (2020)
Ruochen Li, Heng Zhang, Yifan Cao, Xin Liu, Yifan Chen, Yangyang Qi, Jieti Wang, Kuan Yu, Chao Lin, Hao Liu, Hongyong He, He Li, Lingli Chen, Zhenbin Shen, Jing Qin, Weijuan Zhang, Yihong Sun, Jiejie Xu
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer. Cancer immunology, immunotherapy : CII 69 (7) (2020)
Zewei Wang, Quan Zhou, Han Zeng, Hongyu Zhang, Zhaopei Liu, Qiuren Huang, Ying Xiong, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Yu Zhu, Le Xu, Bo Dai, Li Liu, Jianming Guo, Jiejie Xu
Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer. Oncoimmunology 9 (1) (2020)
Yangyang Qi, Yuan Chang, Zewei Wang, Lingli Chen, Yunyi Kong, Peipei Zhang, Zheng Liu, Quan Zhou, Yifan Chen, Jiajun Wang, Qi Bai, Yu Xia, Li Liu, Yu Zhu, Le Xu, Bo Dai, Jianming Guo, Yiwei Wang, Jiejie Xu, Weijuan Zhang
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Cancer immunology, immunotherapy : CII 68 (12) (2019)
Ying Xiong, Li Liu, Yu Xia, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, Yunyi Kong, Yang Qu, Zewei Wang, Zhiyuan Lin, Xiang Chen, Zhuoyi Xiang, Jiajun Wang, Qi Bai, Weijuan Zhang, Yuanfeng Yang, Jianming Guo, Jiejie Xu
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer immunology, immunotherapy : CII 68 (5) (2019)
Chao Lin, Hongyong He, Hao Liu, Ruochen Li, Yifan Chen, Yangyang Qi, Qi Jiang, Lingli Chen, Peipei Zhang, Heng Zhang, He Li, Weijuan Zhang, Yihong Sun, Jiejie Xu
Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut 68 (10) (2019)
Han Zeng, Zheng Liu, Zewei Wang, Quan Zhou, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, Jiajun Wang, Yuan Chang, Qi Bai, Yu Xia, Yiwei Wang, Li Liu, Yu Zhu, Bo Dai, Jianming Guo, Le Xu, Weijuan Zhang, Jiejie Xu
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. International journal of cancer 146 (2) (2019)
Qi Jiang, Qiang Fu, Yuan Chang, Zheng Liu, Junyu Zhang, Le Xu, Yu Zhu, Yiwei Wang, Weijuan Zhang, Jiejie Xu
CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII 68 (1) (2018)
Jiajun Wang, Li Liu, Qi Bai, Chenzhang Ou, Ying Xiong, Yang Qu, Zewei Wang, Yu Xia, Jianming Guo, Jiejie Xu
Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma. Oncoimmunology 8 (1) (2018)
Hangcheng Fu, Yu Zhu, Yiwei Wang, Zheng Liu, Junyu Zhang, Huyang Xie, Qiang Fu, Bo Dai, Dingwei Ye, Jiejie Xu
Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (13) (2018)
Xiaobo Bo, Jie Wang, Tao Suo, Xiaoling Ni, Han Liu, Sheng Shen, Min Li, Yueqi Wang, Houbao Liu, Jiejie Xu
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients. BMC cancer 18 (1) (2018)
Zhiyuan Lin, Li Liu, Yu Xia, Xiang Chen, Ying Xiong, Yang Qu, Jiajun Wang, Qi Bai, Jianming Guo, Jiejie Xu
Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Oncoimmunology 7 (10) (2018)
Zheng Liu, Yu Zhu, Le Xu, Junyu Zhang, Huyang Xie, Hangcheng Fu, Quan Zhou, Yuan Chang, Bo Dai, Jiejie Xu
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer. Oncoimmunology 7 (9) (2018)
Jie Wang, Xiaobo Bo, Tao Suo, Han Liu, Xiaoling Ni, Sheng Shen, Min Li, Jiejie Xu, Houbao Liu, Yueqi Wang
Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer. Cancer science 109 (7) (2018)
Huyang Xie, Yu Zhu, Junyu Zhang, Zheng Liu, Hangcheng Fu, Yifan Cao, Gaoxiang Li, Yijun Shen, Bo Dai, Jiejie Xu, Dingwei Ye
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients. BMC cancer 18 (1) (2018)
Jieti Wang, Chao Lin, He Li, Ruochen Li, Yifan Wu, Hao Liu, Heng Zhang, Hongyong He, Weijuan Zhang, Jiejie Xu
Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer. Oncoimmunology 6 (11) (2017)
Jiajun Wang, Li Liu, Yang Qu, Wei Xi, Yu Xia, Qi Bai, Ying Xiong, Qilai Long, Jiejie Xu, Jianming Guo
HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients. Cancer immunology, immunotherapy : CII 67 (1) (2017)
Yichou Wei, Chao Lin, He Li, Zhiying Xu, Jieti Wang, Ruochen Li, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu
CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Cancer immunology, immunotherapy : CII 67 (2) (2017)